期刊文献+

碳酸钙对阿托伐他汀钙分散片稳定性和溶出度的影响 被引量:1

Effect of Calcium Carbonate on Stability and Dissolution of Atorvastatin Calcium Dispersible Tablets
原文传递
导出
摘要 采用湿法制粒工艺制备阿托伐他汀钙(1)分散片。通过稳定性试验(25℃,相对湿度75%),以1含量和30 min时溶出率为指标,考察了处方中碳酸钙含量对1稳定性的影响。结果表明,碳酸钙含量为22%时片剂中1的稳定性和溶出率均较高。采用正交试验优化了分散片处方中崩解剂用量和加入方式,以及黏合剂用量。优化后1分散片崩解时间约100 s,溶出行为与市售品京舒相似。 The atorvastatin calcium(1) dispersible tablets were prepared by wet granulation method. The influence of calcium carbonate amount was investigated with drug content and dissolution at 30 min of 1 from the tablets stored under the conditions of 25 ℃ and relative humidity of 75% as indexes. The results showed that the tablets containing 22% calcium carbonate were rather stable and had a high dissolution rate. The amount and joining way of disintegrating agent and adhesive amount were optimized by orthogonal experiment. The optimal 1 dispersible tablets could disintegrate within 100 s, and the dissolution behavior of 1 was similar to the commercial product(Jing shu).
机构地区 河南大学药学院
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2016年第4期430-432,共3页 Chinese Journal of Pharmaceuticals
关键词 阿托伐他汀钙 分散片 碳酸钙 稳定性 溶出 atorvastatin calcium dispersible tablet calcium carbonate stability dissolution
  • 相关文献

参考文献4

二级参考文献20

  • 1施明,张学国.辛伐他汀治疗高脂血症患者的疗效观察[J].华西医学,2008,23(5). 被引量:18
  • 2沈海蓉,李中东,施孝金,钟明康.阿托伐他汀钙自微乳的HPLC测定[J].中国医药工业杂志,2005,36(4):223-225. 被引量:7
  • 3LEA AP,MCTAVISH D. Atorvastatin, a review of its pharmacology and therapeutic potential in the management of hyperlipidemias [J]. Drugs, 1997,53(5):828-847.
  • 4BAHRAMI G,MOHAMMADI B,MIRZAEEI S,et al. Determination of atorvastatin in human serum by reversed-phase high-performance liquid chromatography with UV detection[J]. J Chromatogr B,2005,826(2) :41 -45.
  • 5KADAV AA,VORA DN. Stability indicating UPLC method for simuhaneous determination of atorvastatin, fenofibrate and their degradation products in tablets[ J]. J Pharm Biomed Anal,2008, 48(! ) :120 - 126.
  • 6MAZUREK S,SZOSTAK R. Quantification of atorvastatin calcium in tablets by FT-Raman spectroscopy[J]. J Pharm Biorned Anal, 2009,49( 1 ) :168 - 172.
  • 7Sotiriou GG,Cheng JW.Benificial effects of starins in coronary artery disease-beyond lowering cholesterol[J].Ann-Parmacothor,2009,34(12):1432-1439.
  • 8Sotiriou GG,Cheng JW.Benificial effects of starins in coronary artery disease-beyond lowering cholesterol[J].Ann-Parmacothor,2009.34(12):1432-1439.
  • 9Williams JK,Sukhva GK,Tterrington DM,et al.Pravastatin has Cholesterol lowering independent effects on the artery wall of adleroscle rotic monkeys[J].J Am coll Cardiol,2008,31(2):684-691.
  • 10史银凤,杜景柏,巨天赋.丹红注射液联合辛伐他汀治疗高脂血症近期疗效观察[J].中西医结合心脑血管病杂志,2008,6(5):600-601. 被引量:9

共引文献36

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部